Format

Send to

Choose Destination
Europace. 2015 May;17(5):814-8. doi: 10.1093/europace/euu390. Epub 2015 Feb 20.

Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.

Author information

1
Cliniques du Sud Luxembourg, Arlon, Belgium.
2
Karolinska University Hospital, Stockholm, Sweden.
3
IRCCS Fondazione Policlinico S Matteo, Pavia, Italy.
4
Imperial College London (Royal Brompton Hospital), London, UK.
5
Aston University Medical School, Queen Elizabeth Hospital, Birmingham, UK cardiologists@hotmail.com.

Abstract

Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) permits early detection of arrhythmias, device, and lead failure and may also be useful in risk-predicting patient-related outcomes. Financial benefits for patients and healthcare organizations have also been shown. We sought to assess the implementation and funding of RM of CIEDs, including conventional pacemakers (PMs), implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices in Europe. Electronic survey from 43 centres in 15 European countries. In the study sample, RM was available in 22% of PM patients, 74% of ICD patients, and 69% of CRT patients. The most significant perceived benefits were the early detection of atrial arrhythmias in pacemaker patients, lead failure in ICD patients, and worsening heart failure in CRT patients. Remote monitoring was reported to lead a reduction of in-office follow-ups for all devices. The most important reported barrier to the implementation of RM for all CIEDs was lack of reimbursement (80% of centres). Physicians regard RM of CIEDs as a clinically useful technology that affords significant benefits for patients and healthcare organizations. Remote monitoring, however, is perceived as increasing workload. Reimbursement for RM is generally perceived as a major barrier to implementation.

KEYWORDS:

Cardiac resynchronization therapy; Heart failure; Implantable cardioverter defibrillator; Pacemaker; Remote monitoring; Telemonitoring

PMID:
25713012
DOI:
10.1093/europace/euu390
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center